RPID

$2.95-0.02 (-0.67%)

Market OpenAs of Mar 17, 7:05 PM UTC

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$2.95
Potential Upside
5%
Whystock Fair Value$3.10
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switze...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$130.75M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.39
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-86.82%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
2.27

Recent News

GuruFocus.com
Mar 12, 2026

Rapid Micro Biosystems Inc (RPID) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid ...

Despite a 37% revenue surge, Rapid Micro Biosystems Inc (RPID) faces margin pressures and increased net loss, while strategic partnerships and system placements show promising growth.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Moby
Mar 12, 2026

Rapid Micro Biosystems, Inc. Q4 2025 Earnings Call Summary

Moby summary of Rapid Micro Biosystems, Inc.'s Q4 2025 earnings call

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
MarketBeat
Mar 12, 2026

Rapid Micro Biosystems Q4 Earnings Call Highlights

Rapid Micro Biosystems (NASDAQ:RPID) reported fourth-quarter and full-year 2025 results highlighting record quarterly revenue, increased system placements, and expanding recurring revenue, while also outlining expectations for revenue growth and gross margin improvement in 2026. Fourth-quarter resu

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 12, 2026

February 2026's Standout Penny Stocks To Consider

As February begins, the U.S. stock market is off to a strong start, with major indexes like the Dow Jones and S&P 500 posting significant gains. In such a buoyant market environment, investors often look beyond traditional stocks for opportunities that might offer substantial returns at lower entry points. Penny stocks, while an outdated term, still represent an intriguing investment area where smaller or newer companies can provide growth potential when underpinned by solid financials and...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Jan 5, 2026

3 Penny Stocks With Market Caps Under $200M To Watch

The U.S. stock market has been experiencing a surge, with major indices like the Dow Jones hitting all-time highs, driven by geopolitical developments and strong performances in sectors such as energy. For investors willing to explore beyond the well-known giants, penny stocks—often representing smaller or emerging companies—can present intriguing opportunities. Despite being an older term, these stocks remain relevant for those seeking potential value in less-established firms with solid...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.